USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: VENTRIA BIOSCIENCE
City: FORT COLLINS
State: CO
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $2,242,303.00 12
SBIR Phase II $4,936,182.00 5
STTR Phase I $201,920.00 1

Award List:

Lactoferrin prevents biofilm formation at wound

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ning Huang
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): Wound healing is a major health issue for the elderly. Biofilm development at the wound site renders many existing treatments ineffective in treating wound pathogens because when bacteria is protected by biofilm it increases its resistance to antibiotics.… More

Use of recombinant human lactoferrin for wounds by stimulating cell growth

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ning Huang
Award Amount: $113,851.00
Abstract:
DESCRIPTION (provided by applicant): Acute and chronic wound care continues to pose major challenges in both civilian and military forces. It is estimated that 6 million people in the United States were affected by chronic wounds, such as venous ulcers. As of November 2005, 15,568 US soldiers in… More

Recombinant human defensin for management of ileal Crohn's disease

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ning Huang
Award Amount: $189,300.00
Abstract:
DESCRIPTION (provided by applicant): Inflammatory bowel disease (IBD), including Crohn's disease, is a chronic inflammation of the intestine, for which current therapies are inadequate. In industrialized countries, Crohn's disease affects about 1 in 500 individuals, and it is estimated that about… More

Recombinant human serum albumin for therapeutic use

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ning Huang
Award Amount: $99,500.00
Abstract:
DESCRIPTION (provided by applicant): Due to the potential risk of disease contamination of human serum albumin (HSA) derived from fractionation of pooled donor blood and the increasing demand of HSA in therapeutic applications, production of recombinant human serum albumin (rHSA) has become… More

Recombinant human serum albumin for use in cell culture media

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ning Huang
Award Amount: $99,982.00
Abstract:
DESCRIPTION (provided by applicant): Plasma-derived human serum albumin (pHSA) or bovine serum albumin are commonly added to cell culture media used in cell culture-based vaccine and therapeutic production, because it enhances cell growth and increases pr otein productivity. However, the use of… More

Production of OspA in rice for the control of Lyme Disease

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ning Huang
Award Amount: $126,530.00
Abstract:
DESCRIPTION (provided by applicant): A vaccine for humans against Lyme disease caused by B. burgdorferi is currently not available due to market acceptance and safety of an injectable vaccine based on outer surface protein A (OspA). An alternate approach t o protecting humans from Lyme disease is to… More

Recombinant Human Serum Albumin for Use in Cell Culture

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ning Huang
Award Amount: $724,628.00
Abstract:
DESCRIPTION (provided by applicant): Plasma-derived human serum albumin (pHSA) or bovine serum albumin are commonly added to cell culture media used in cell culture-based vaccine and therapeutic production, because it enhances cell growth and increases pro tein productivity. However, the use of pHSA… More

Expression of Human Transferrin in Rice Grain

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Deshui Zhang
Award Amount: $119,592.00
Abstract:
DESCRIPTION (provided by applicant): Transferrin is an essential ingredient used in cell culture media due to its crucial role in regulating cellular iron uptake, transport, and utilization, and also a promising drug carrier to increase drug therapeutic in dex via its unique transferrin… More

Production of OspA in rice for the control of Lyme disease

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ning Huang
Award Amount: $1,052,604.00
Abstract:
DESCRIPTION (provided by applicant): A vaccine for humans against Lyme disease caused by B. burgdorferi is currently not available due to poor market acceptance and safety concerns of an injectable vaccine based on outer surface protein A (OspA). An altern ative approach to protecting humans from… More

Lactoferrin for the prevention of antibiotic-associated diarrhea in adult

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ning Huang
Award Amount: $538,324.00
Abstract:
DESCRIPTION (provided by applicant): Patients treated with antibiotics frequently develop diarrhea. In developed countries, adults, particularly the elderly, experience a higher death rate due to diarrhea than children. Results from in vitro and preliminar y in vivo studies lead us to hypothesize… More

Recombinant production of human transferrin for cell culture

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Deshui Zhang
Award Amount: $799,658.00
Abstract:
DESCRIPTION (provided by applicant): Transferrin plays a crucial role in controlling cell growth and survival by regulating cellular iron uptake, transport and utilization, and thus is an essential culture media ingredient used for cell culture-based produ ction of therapeutic proteins and vaccines.… More

Lactoferrin for the prevention of antibiotic-associated diarrhea in adult

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ning Huang – 916-838-3467
Award Amount: $842,421.00
Abstract:
DESCRIPTION (provided by applicant): Patients treated with antibiotics frequently develop diarrhea. In developed countries, adults, particularly the elderly, experience a higher death rate due to diarrhea than children. Results from in vitro and preliminary in vivo studies lead us to hypothesize… More

Robust, animal-free cell culture medium for the production of vaccines

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Steve C. Pettit – 919-824-9867
Award Amount: $158,820.00
Abstract:
DESCRIPTION (provided by applicant): Epithelial cell lines such as Vero and MDCK are used in the production of viral based vaccines. The use of cell based vaccines is growing. The majority of the vaccines in use today are produced in medium supplemented with serum. The use of animal-derived products… More

Low cost production of rabies virus antigens in rice grain

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ning Huang – 530-792-1419
Award Amount: $226,554.00
Abstract:
DESCRIPTION (provided by applicant): Rabies is the 10th most lethal infectious diseases in the world, causing approximately 60,000 deaths annually. Rabies is invariably fatal once symptoms occur. Prevention is the key in rabies control. In the US, rabies remains a significant wildlife- management… More

Robust, defined, animal-free cell culture medium for the production of vaccines

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Steve C. Pettit – 919-824-9867
Award Amount: $1,516,871.00
Abstract:
DESCRIPTION (provided by applicant): The Vero cell line is used in the production of viral based vaccines. The use of cell based vaccines based on the Vero cell line is growing. The majority of the vaccines in use today are produced using cell culture medium supplemented with serum. The use of… More

Human Lactoferrin in Acetaminophen Overdose-Induced Liver Failure

Award Year / Program / Phase: 2012 / STTR / Phase I
Agency: HHS
Research Institution: UNIVERSITY OF COLORADO DENVER/HSC DENVER
Principal Investigator: Cynthia Ju – 303-724-4019
Award Amount: $201,920.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): An acute or cumulative overdose of acetaminophen (APAP), following either therapeutic overdose or suicide attempts, can cause severe liver damage with the potential to progress to liver failure. APAP overdose accounts for more than 56,000 emergency room visits,… More

Production of human MUC17 (CRD1-L-CRD2) recombinant protein in rice for the treat

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ning Huang – 916-838-3467
Award Amount: $237,323.00
Abstract:
DESCRIPTION (provided by applicant): Recent studies in animal models demonstrate that an endogenous human intestinal mucin fragment, termed MUC17, augments intestinal cell restitution and enhances healing of experimental colitis, potentially opening a newdoor to effective treatment of ulcerative… More

Low-cost proinsulin-transferrin fusion protein in rice for treatment of diabetes

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Deshui Zhang – 530-972-1419
Award Amount: $232,527.00
Abstract:
DESCRIPTION (provided by applicant): Diabetes has become a devastating epidemic worldwide. Insulin is commonly used as a treatment to help manage diabetes because of its ability to control blood glucose levels, and is in high demand worldwide, but it facesmultiple challenges including adverse… More